Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inge Nordgaard-Lassen

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Inflammatory Bowel Diseases|February 27, 2016
Fecal Calprotectin Predicts Relapse and Histological Mucosal Healing in Ulcerative ColitisKlaus Theede, Susanne Holck, Per Ibsen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 9, 2015
Level of Fecal Calprotectin Correlates With Endoscopic and Histologic Inflammation and Identifies Patients With Mucosal Healing in Ulcerative ColitisKlaus Theede, Susanne Holck, Per Ibsen, et al.
Obesity Facts|August 30, 2017
S100A8/A9 (Calprotectin), Interleukin-6, and C-Reactive Protein in Obesity and Diabetes before and after Roux-en-Y Gastric Bypass SurgeryLouise Lylloff, Lise Bathum, Sten Madsbad, et al.
European Journal of Nutrition|January 21, 2014
Nutritional intake and status in persons with alcohol dependency: data from an outpatient treatment programmeAnne Wilkens Knudsen, Jens-Erik Beck Jensen, Inge Nordgaard-Lassen, et al.
Scandinavian Journal of Gastroenterology|December 18, 2015
Effect of paracentesis on metabolic activity in patients with advanced cirrhosis and ascitesAnne Wilkens Knudsen, Aleksander Krag, Inge Nordgaard-Lassen, et al.
Scandinavian Journal of Gastroenterology|April 17, 2015
Nutrition impact symptoms, handgrip strength and nutritional risk in hospitalized patients with gastroenterological and liver diseasesAnne Wilkens Knudsen, Astrid Naver, Karen Bisgaard, et al.
Journal of Crohn'S & Colitis|June 29, 2014
Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trialAndreas Munk Petersen, Hengameh Mirsepasi, Sofie Ingdam Halkjær, et al.
Danish Medical Journal|June 8, 2013
Biologic therapy in inflammatory bowel diseaseKlaus Theede, Jens Frederik Dahlerup, Jan Fallingborg, et al.
Scandinavian Journal of Gastroenterology|December 14, 2011
Seroreactivity to E. coli outer membrane protein C antibodies in active inflammatory bowel disease; diagnostic value and correlation with phylogroup B2 E. coli infectionAndreas Munk Petersen, Christian Schou, Hengameh Mirsepasi, et al.
Scientific Reports|October 1, 2016
Extraintestinal pathogenic Escherichia coli are associated with intestinal inflammation in patients with ulcerative colitisHengameh C Mirsepasi-Lauridsen, Sofie Ingdam Halkjaer, Esben Munk Mortensen, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Inflammatory Bowel Diseases|February 27, 2016
Fecal Calprotectin Predicts Relapse and Histological Mucosal Healing in Ulcerative ColitisKlaus Theede, Susanne Holck, Per Ibsen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 9, 2015
Level of Fecal Calprotectin Correlates With Endoscopic and Histologic Inflammation and Identifies Patients With Mucosal Healing in Ulcerative ColitisKlaus Theede, Susanne Holck, Per Ibsen, et al.
Obesity Facts|August 30, 2017
S100A8/A9 (Calprotectin), Interleukin-6, and C-Reactive Protein in Obesity and Diabetes before and after Roux-en-Y Gastric Bypass SurgeryLouise Lylloff, Lise Bathum, Sten Madsbad, et al.
European Journal of Nutrition|January 21, 2014
Nutritional intake and status in persons with alcohol dependency: data from an outpatient treatment programmeAnne Wilkens Knudsen, Jens-Erik Beck Jensen, Inge Nordgaard-Lassen, et al.
Scandinavian Journal of Gastroenterology|December 18, 2015
Effect of paracentesis on metabolic activity in patients with advanced cirrhosis and ascitesAnne Wilkens Knudsen, Aleksander Krag, Inge Nordgaard-Lassen, et al.
Scandinavian Journal of Gastroenterology|April 17, 2015
Nutrition impact symptoms, handgrip strength and nutritional risk in hospitalized patients with gastroenterological and liver diseasesAnne Wilkens Knudsen, Astrid Naver, Karen Bisgaard, et al.
Journal of Crohn'S & Colitis|June 29, 2014
Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trialAndreas Munk Petersen, Hengameh Mirsepasi, Sofie Ingdam Halkjær, et al.
Danish Medical Journal|June 8, 2013
Biologic therapy in inflammatory bowel diseaseKlaus Theede, Jens Frederik Dahlerup, Jan Fallingborg, et al.
Scandinavian Journal of Gastroenterology|December 14, 2011
Seroreactivity to E. coli outer membrane protein C antibodies in active inflammatory bowel disease; diagnostic value and correlation with phylogroup B2 E. coli infectionAndreas Munk Petersen, Christian Schou, Hengameh Mirsepasi, et al.
Scientific Reports|October 1, 2016
Extraintestinal pathogenic Escherichia coli are associated with intestinal inflammation in patients with ulcerative colitisHengameh C Mirsepasi-Lauridsen, Sofie Ingdam Halkjaer, Esben Munk Mortensen, et al.
Pageof 3